ATE269543T1 - Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen - Google Patents

Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen

Info

Publication number: ATE269543T1
Authority: AT; Austria
Prior art keywords: autoimmune diseases; disease; diagnosis; transglutaminases; sample
Prior art date: 1999-06-28

Application number

AT00943925T

Other languages

English (en)

Inventor

Mats Paulsson

Stelzmann-Str

Miklos Sardy

Uwe Odenthal

Sarolta Karpati

U Maria

Neil Smyth

Daniel Aeschlimann

Original Assignee

Immundiagnostik Ag

Wieslab Ab

Mats Paulsson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-28

Filing date

2000-06-28

Publication date

2004-07-15

2000-06-28 Application filed by Immundiagnostik Ag, Wieslab Ab, Mats Paulsson filed Critical Immundiagnostik Ag

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE269543T1 publication Critical patent/ATE269543T1/de

Links

208000023275 Autoimmune disease Diseases 0.000 title abstract 4
238000003745 diagnosis Methods 0.000 title abstract 2
108010068370 Glutens Proteins 0.000 title 1
235000021312 gluten Nutrition 0.000 title 1
230000035945 sensitivity Effects 0.000 title 1
208000015943 Coeliac disease Diseases 0.000 abstract 2
208000010159 IgA glomerulonephritis Diseases 0.000 abstract 2
108060008539 Transglutaminase Proteins 0.000 abstract 2
206010012601 diabetes mellitus Diseases 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
102000003601 transglutaminase Human genes 0.000 abstract 2
208000026872 Addison Disease Diseases 0.000 abstract 1
208000004300 Atrophic Gastritis Diseases 0.000 abstract 1
206010003694 Atrophy Diseases 0.000 abstract 1
208000008439 Biliary Liver Cirrhosis Diseases 0.000 abstract 1
208000033222 Biliary cirrhosis primary Diseases 0.000 abstract 1
206010008609 Cholangitis sclerosing Diseases 0.000 abstract 1
206010009900 Colitis ulcerative Diseases 0.000 abstract 1
208000011231 Crohn disease Diseases 0.000 abstract 1
206010012468 Dermatitis herpetiformis Diseases 0.000 abstract 1
208000036495 Gastritis atrophic Diseases 0.000 abstract 1
101000666171 Homo sapiens Protein-glutamine gamma-glutamyltransferase 2 Proteins 0.000 abstract 1
206010021263 IgA nephropathy Diseases 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
208000031845 Pernicious anaemia Diseases 0.000 abstract 1
206010065159 Polychondritis Diseases 0.000 abstract 1
208000012654 Primary biliary cholangitis Diseases 0.000 abstract 1
208000021386 Sjogren Syndrome Diseases 0.000 abstract 1
206010043561 Thrombocytopenic purpura Diseases 0.000 abstract 1
208000024799 Thyroid disease Diseases 0.000 abstract 1
201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
206010047115 Vasculitis Diseases 0.000 abstract 1
206010047642 Vitiligo Diseases 0.000 abstract 1
206010000210 abortion Diseases 0.000 abstract 1
231100000176 abortion Toxicity 0.000 abstract 1
230000037444 atrophy Effects 0.000 abstract 1
208000016644 chronic atrophic gastritis Diseases 0.000 abstract 1
208000025302 chronic primary adrenal insufficiency Diseases 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
230000004578 fetal growth Effects 0.000 abstract 1
208000007475 hemolytic anemia Diseases 0.000 abstract 1
208000000509 infertility Diseases 0.000 abstract 1
231100000535 infertility Toxicity 0.000 abstract 1
230000036512 infertility Effects 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
206010028417 myasthenia gravis Diseases 0.000 abstract 1
206010053857 partial lipodystrophy Diseases 0.000 abstract 1
208000008494 pericarditis Diseases 0.000 abstract 1
208000005987 polymyositis Diseases 0.000 abstract 1
201000000742 primary sclerosing cholangitis Diseases 0.000 abstract 1
230000000306 recurrent effect Effects 0.000 abstract 1
208000009169 relapsing polychondritis Diseases 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
201000000306 sarcoidosis Diseases 0.000 abstract 1
208000010157 sclerosing cholangitis Diseases 0.000 abstract 1
230000003393 splenic effect Effects 0.000 abstract 1
230000009885 systemic effect Effects 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Rehabilitation Therapy (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Rheumatology (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)

AT00943925T 1999-06-28 2000-06-28 Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen ATE269543T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99111975		1999-06-28
PCT/EP2000/006025 WO2001001133A2 (en)	1999-06-28	2000-06-28	Diagnosis of gluten sensitive enteropathy and other autoimmunopathies

Publications (1)

Publication Number	Publication Date
ATE269543T1 true ATE269543T1 (de)	2004-07-15

Family

ID=8238394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00943925T ATE269543T1 (de)	1999-06-28	2000-06-28	Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen

Country Status (8)

Country	Link
US (1)	US7781169B1 (de)
EP (1)	EP1200827B1 (de)
JP (1)	JP2003521677A (de)
AT (1)	ATE269543T1 (de)
AU (1)	AU776091B2 (de)
CA (1)	CA2377733C (de)
DE (1)	DE60011622T2 (de)
WO (1)	WO2001001133A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20010868A0 (fi) *	2001-04-25	2001-04-25	Markku Maeki	Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
US7265093B2 (en) *	2002-05-14	2007-09-04	The Board Of Trustees Of The Leland Stanford Junior University	Drug therapy for Celiac Sprue
JP4512828B2 (ja) *	2005-04-12	2010-07-28	国立大学法人千葉大学	肺サルコイドーシスおよび眼サルコイドーシスの検出マーカー及び検出キット
EP1978364B1 (de)	2007-04-06	2011-06-01	Zedira GmbH	Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen
JP5120570B2 (ja) *	2010-02-15	2013-01-16	国立大学法人千葉大学	肺サルコイドーシスおよび眼サルコイドーシスの検出マーカー及び検出キット
CN107831318B (zh) *	2011-01-20	2021-06-18	西瑞斯实验室有限公司	检测谷蛋白敏感性和其区分于乳糜泻的方法和装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994010296A1 (en)	1992-11-03	1994-05-11	Oklahoma Medical Research Foundation	Transglutaminase gene
DE19630557C2 (de) *	1996-07-18	1998-07-02	Schuppan Detlef Priv Doz Dr Dr	Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie

2000
- 2000-06-28 AT AT00943925T patent/ATE269543T1/de active
- 2000-06-28 AU AU58214/00A patent/AU776091B2/en not_active Ceased
- 2000-06-28 JP JP2001507087A patent/JP2003521677A/ja not_active Withdrawn
- 2000-06-28 EP EP00943925A patent/EP1200827B1/de not_active Expired - Lifetime
- 2000-06-28 DE DE60011622T patent/DE60011622T2/de not_active Expired - Lifetime
- 2000-06-28 WO PCT/EP2000/006025 patent/WO2001001133A2/en not_active Ceased
- 2000-06-28 US US10/019,067 patent/US7781169B1/en not_active Expired - Lifetime
- 2000-06-28 CA CA2377733A patent/CA2377733C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU776091B2 (en)	2004-08-26
WO2001001133A3 (en)	2001-04-19
JP2003521677A (ja)	2003-07-15
WO2001001133A2 (en)	2001-01-04
DE60011622D1 (de)	2004-07-22
EP1200827B1 (de)	2004-06-16
US7781169B1 (en)	2010-08-24
CA2377733C (en)	2012-06-05
DE60011622T2 (de)	2005-09-08
AU5821400A (en)	2001-01-31
EP1200827A2 (de)	2002-05-02
CA2377733A1 (en)	2001-01-04

Legal Events

Date

Code

Title

Description

2005-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1200827

Country of ref document: EP

Publication	Publication Date	Title
DK1706024T3 (da)	2012-08-13	Integreret diagnostisk testsystem
ATE361470T1 (de)	2007-05-15	Verfahren zur diagnose von immunologischer lebensmittelsensitivität
DK1563300T3 (da)	2012-07-23	Diagnostisk fremgangsmåde til cøliaki
DE602004021367D1 (de)	2009-07-16	Verfahren zur beurteilung des phänotyps eines patienten mit morbus crohn über eine serologische i2-, ompc- und asca-reaktion
WO2007019411A3 (en)	2007-06-14	Peptides for diagnostic and therapeutic methods for celiac sprue
WO2004036180A3 (en)	2005-03-03	Systems and methods for the detection of short and long samples
ATE269543T1 (de)	2004-07-15	Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen
EP2322932A3 (de)	2011-11-09	Nachweis von Tuberkulose und Infektion durch mycobacterium tuberculosis mittels HBHA
DE59504926D1 (de)	1999-03-04	Vorrichtung und verfahren zur gravitationsmessung
Barak et al.	2013	Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines.
ATE370414T1 (de)	2007-09-15	Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE60233107D1 (de)	2009-09-10	Teststreifen enthaltend Kontrollmittel und Zeitsetzermittel
CA2464466A1 (en)	2003-05-01	Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae
TW200507144A (en)	2005-02-16	Automatic test system with easily modified software
EP1432731A4 (de)	2005-03-16	Diagnose und aufzeichnung von systemischem lupus erythematosus und von skleroderm
Marai et al.	2004	IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus
ATE243758T1 (de)	2003-07-15	Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
ATE147410T1 (de)	1997-01-15	Igm-antikörper gegen protamin
WO2006028576A3 (en)	2006-08-24	Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor
DE602006010535D1 (de)	2009-12-31	System zur erfassungsverwaltung
BR0209172A (pt)	2004-08-03	Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
TR199700344A2 (xx)	1999-10-21	Dio-sensitest h�zl� antibakteriyel duyarl�l�k testi.
JPS5438131A (en)	1979-03-22	Toner concentration detecting method of dry type two component developer
TW200644694A (en)	2006-12-16	Diagnostic device for automotive remote control system
WO2006112962A3 (en)	2006-12-28	Syphilis diagnostic test and kits